Clinical Trial Update: Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating nab-paclitaxel with local therapy for relapsed small cell lung cancer (extensive stage). The study status is NOT_YET_RECRUITI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Small Cell Lung Cancer, Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Phase 2 | Status: NOT_YET_RECRUITING